Szilárd Vasas

4 papers receiving 202 citations

Hit Papers

Plozasiran, an RNA Interference Agent Targeting APOC3, fo...202320262024202520242023255075100

Peers

Szilárd Vasas
Comparison fields: 5 of 38
  • Endocrinology, Diabetes and Metabolism 132
  • Surgery 82
  • Cardiology and Cardiovascular Medicine 56
  • Molecular Biology 55
  • Pharmacology 37
Replace S. Baillot-Rudoni with:
S. Baillot-Rudoni France
Hajime Kihara Japan
Alena Welters Germany
Diego Bailetti Italy
Ekaterina А. Shestakova Russia
Liisa Hakaste Finland
Samantha Ho United States
Maki Kimura-Koyanagi Japan
Elena Venturi Italy
Szilárd Vasas relative to S. Baillot-Rudoni France S. Baillot-Rudoni's profile →
Citations per field
00.5×6.1×
S. Baillot-Rudoni · 1×
Citations per year

Countries citing papers authored by Szilárd Vasas

Since Specialization
Citations

This map shows the geographic impact of Szilárd Vasas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Szilárd Vasas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Szilárd Vasas more than expected).

Fields of papers citing papers by Szilárd Vasas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Szilárd Vasas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Szilárd Vasas. The network helps show where Szilárd Vasas may publish in the future.

Co-authorship network of co-authors of Szilárd Vasas

This figure shows the co-authorship network connecting the top 25 collaborators of Szilárd Vasas. A scholar is included among the top collaborators of Szilárd Vasas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Szilárd Vasas. Szilárd Vasas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 0
2
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemiabreakdown →
103
3 13
4 0
5
Efficacy and Safety of Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron for Glycemic Control Among Patients With Type 2 Diabetesbreakdown →
86
6 4

About Szilárd Vasas

Szilárd Vasas is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 6 papers that have together received 206 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (2 papers), Lipid metabolism and disorders (2 papers) and Lipoproteins and Cardiovascular Health (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (132 citations), Cardiology and Cardiovascular Medicine (56 citations) and Pharmacology (37 citations). Szilárd Vasas has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Nikolaos Tsamandouras, Juan P. Frías, Morris J. Birnbaum, Lisa Brown, Aditi R. Saxena, Donal Gorman, Robert S. Rosenson, Christie M. Ballantyne, Stacey Melquist and Masoud Azizad. Their work appears in journals such as New England Journal of Medicine, Circulation and Diabetes Obesity and Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026